184 related articles for article (PubMed ID: 11918684)
21. [The numerous properties of the anticoagulant protein C].
Cerchiara E; Tirindelli MC; Giannetti B; Dicuonzo G; Avvisati G
Clin Ter; 2007; 158(2):181-7. PubMed ID: 17566522
[TBL] [Abstract][Full Text] [Related]
22. Protein C in critical illness.
Mann HJ; Short MA; Schlichting DE
Am J Health Syst Pharm; 2009 Jun; 66(12):1089-96. PubMed ID: 19498123
[TBL] [Abstract][Full Text] [Related]
23. Crosstalk between inflammation and thrombosis.
Esmon CT
Maturitas; 2004 Apr; 47(4):305-14. PubMed ID: 15063484
[TBL] [Abstract][Full Text] [Related]
24. Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats.
Uchiba M; Okajima K; Murakami K; Nawa K; Okabe H; Takatsuki K
Thromb Haemost; 1995 Nov; 74(5):1265-70. PubMed ID: 8607107
[TBL] [Abstract][Full Text] [Related]
25. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
Iba T; Thachil J
Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
[TBL] [Abstract][Full Text] [Related]
26. Biochemical strategies to anticoagulation: a comparative overview.
Chu AJ
Curr Vasc Pharmacol; 2004 Jul; 2(3):199-228. PubMed ID: 15320820
[TBL] [Abstract][Full Text] [Related]
27. Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III.
Uchiba M; Okajima K
Semin Thromb Hemost; 1997; 23(6):583-90. PubMed ID: 9469634
[TBL] [Abstract][Full Text] [Related]
28. Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes.
Brueckmann M; Hoffmann U; De Rossi L; Weiler HM; Liebe V; Lang S; Kaden JJ; Borggrefe M; Haase KK; Huhle G
Cytokine; 2004 May; 26(3):106-13. PubMed ID: 15135804
[TBL] [Abstract][Full Text] [Related]
29. The impact of the inflammatory response on coagulation.
Esmon CT
Thromb Res; 2004; 114(5-6):321-7. PubMed ID: 15507261
[TBL] [Abstract][Full Text] [Related]
30. Inflammation, sepsis, and coagulation.
Esmon CT; Fukudome K; Mather T; Bode W; Regan LM; Stearns-Kurosawa DJ; Kurosawa S
Haematologica; 1999 Mar; 84(3):254-9. PubMed ID: 10189392
[TBL] [Abstract][Full Text] [Related]
31. Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation.
Slofstra SH; van 't Veer C; Buurman WA; Reitsma PH; ten Cate H; Spek CA
Crit Care Med; 2005 Jun; 33(6):1365-70. PubMed ID: 15942357
[TBL] [Abstract][Full Text] [Related]
32. Ethyl pyruvate exerts combined anti-inflammatory and anticoagulant effects on human monocytic cells.
van Zoelen MA; Bakhtiari K; Dessing MC; van't Veer C; Spek CA; Tanck M; Meijers JC; van der Poll T
Thromb Haemost; 2006 Dec; 96(6):789-93. PubMed ID: 17139374
[TBL] [Abstract][Full Text] [Related]
33. Gabexate mesilate, a synthetic protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappaB and activator protein-1 in human monocytes.
Yuksel M; Okajima K; Uchiba M; Okabe H
J Pharmacol Exp Ther; 2003 Apr; 305(1):298-305. PubMed ID: 12649382
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effects of activated protein C on intrauterine inflammation-induced neonatal white matter injury are associated with the downregulation of fibrinogen-like protein 2/fibroleukin prothrombinase and the inhibition of pro-inflammatory cytokine expression.
Jin SJ; Liu Y; Deng SH; Liao LH; Lin TL; Ning Q; Luo XP
Int J Mol Med; 2015 May; 35(5):1199-212. PubMed ID: 25777531
[TBL] [Abstract][Full Text] [Related]
35. Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line.
White B; Schmidt M; Murphy C; Livingstone W; O'Toole D; Lawler M; O'Neill L; Kelleher D; Schwarz HP; Smith OP
Br J Haematol; 2000 Jul; 110(1):130-4. PubMed ID: 10930989
[TBL] [Abstract][Full Text] [Related]
36. Coagulation inhibitor replacement during sepsis: useless?
Hoffman JN; Faist E
Crit Care Med; 2000 Sep; 28(9 Suppl):S74-6. PubMed ID: 11007203
[TBL] [Abstract][Full Text] [Related]
37. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.
Van Walderveen MC; Berry LR; Atkinson HM; Chan AK
Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984
[TBL] [Abstract][Full Text] [Related]
38. A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes.
Grey ST; Hancock WW
J Immunol; 1996 Mar; 156(6):2256-63. PubMed ID: 8690916
[TBL] [Abstract][Full Text] [Related]
39. Crosstalk between inflammation and thrombosis.
Esmon CT
Maturitas; 2008; 61(1-2):122-31. PubMed ID: 19437587
[TBL] [Abstract][Full Text] [Related]
40. Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes.
Schmidt-Supprian M; Murphy C; While B; Lawler M; Kapurniotu A; Voelter W; Smith O; Bernhagen J
Eur Cytokine Netw; 2000 Sep; 11(3):407-13. PubMed ID: 11022125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
